Weight Loss Programs for Kidney Cancer Prevention
This study is comparing two different weight loss programs, Intermittent Fasting (IF) and Continuous Energy Restriction (CER), for people with small kidney (renal) cancer masses who are under active surveillance (AS). The goal is to see if these programs can help prevent the cancer from getting worse. You could be eligible if you are an English-speaking adult (18+) with a biopsy-confirmed kidney cancer mass, are on active surveillance for less than 5 years, and have a BMI of 25 or higher. The study aims to see how many people participate in each program over 6 months. This study is currently recruiting about 20 participants.
- Study design
- This interventional study compares two different weight loss programs, Intermittent Fasting and Continuous Energy Restriction, with about 20 participants.
- What's involved
- You would participate in either the Intermittent Fasting or Continuous Energy Restriction program, which includes self-monitoring and feedback from an interventionist.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, participation rate, is measured at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Participation RateAt 6 months
This will assess the rate of eligible persons who enroll after invitation and the mean proportion of intervention components completed by arm and participant